Efficacy of treatments tested in COVID-19 patients with cardiovascular disease. A meta-analysis.
Soumaya Ben-Aicha GonzalezJacqueline BuchananPrakash P PunjabiCostanza EmanueliMarco MoscarelliPublished in: Perfusion (2022)
COVID-19 is associated with a high in-hospital mortality rate in patients with CVD. This study shows that previous CVD determines mortality, regardless of the type of COVID-19 administered therapy. Treatments for at-risk patients should be administered carefully and monitored closely until further data are available.
Keyphrases
- coronavirus disease
- sars cov
- cardiovascular disease
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- type diabetes
- cardiovascular events
- prognostic factors
- peritoneal dialysis
- electronic health record
- risk factors
- coronary artery disease
- big data
- artificial intelligence
- patient reported